Therefore, there are at least two potential modes of action proposed for TRIM28 acting as a facilitator of cancer stemness (in accordance with KRAB-ZNFs): (i) TRIM28 switches off the expression of differentiating genes and/or (ii) TRIM28 enhances the expression of pluripotency markers. The gene discussed is TRIM28; the disease is cancer.